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ExtrA ViEw
Self-assembly of proteins and pep-tides into amyloid structures has 
been the subject of intense and focused 
research due to their association with 
neurodegenerative, age-related human 
diseases and transmissible prion dis-
eases in humans and mammals. Of the 
disease associated amyloid assemblies, 
a diverse array of species, ranging from 
small oligomeric assembly intermedi-
ates to fibrillar structures, have been 
shown to have toxic potential. Equally, 
a range of species formed by the same 
disease associated amyloid sequences 
have been found to be relatively benign 
under comparable monomer equivalent 
concentrations and conditions. In recent 
years, an increasing number of func-
tional amyloid systems have also been 
found. These developments show that 
not all amyloid structures are generically 
toxic to cells. Given these observations, 
it is important to understand why amy-
loid structures may encode such varied 
toxic potential despite sharing a common 
core molecular architecture. Here, we 
discuss possible links between different 
aspects of amyloidogenic structures and 
assembly mechanisms with their varied 
functional effects. We propose testable 
hypotheses for the relationship between 
amyloid structure and its toxic potential 
in the context of recent reports on amy-
loid sequence, structure, and toxicity 
relationships.
From Sequence to Amyloid 
Structure
Amyloid fibrils are highly organized 
and stable structures composed of proteins 
that are able to self-assemble via β-sheet 
association. The core of all amyloid 
fibrils adopt what is commonly known 
as the cross-β structure, named due to 
the arrangement in which β-strands that 
run perpendicular to the fiber axis form 
β-sheet ribbons or filaments that fur-
ther associate to form amyloid fibrils.1 
These fibrils are found in a large number 
of protein misfolding diseases includ-
ing Alzheimer disease, type 2 diabetes 
mellitus, and transmissible spongiform 
encephalopathies.2 Peptides and proteins 
with different sequences are able to read-
ily form amyloid-like fibrils. Thus, the 
sequence determinants of amyloid self-
assembly have been an area of intense 
research. Algorithms have been developed 
to analyze amino acid sequences and to 
predict their propensity to form amyloid. 
These have used properties such as β-sheet 
propensity and hydrophobicity3,4 or more 
complex methods to look at the relation-
ship between the arrangement of the 
amino acids and the final cross-β struc-
ture.5,6 From these studies, it has become 
clear that many short peptides have a high 
propensity to form amyloid fibrils6; over 
50 have been identified to date and the 
number is growing. Recent advances in 
characterizing the structural properties 
of amyloid fibrils show an increasingly 
detailed atomic resolution picture of the 
cross-β structure. X-ray crystallography 
provides structural information, showing 
that small amyloid forming peptides are 
able to form steric zippers in which side 
chains associate and interlock between the 
β-sheets.7 X-ray fiber diffraction8,9 and 
solid-state NMR10-12 have been used to 
examine the structure of the fibrils them-
selves, and show similar complementarity 
between the side chain interactions across 
the sheets. These observations further 
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anchor the notion of a similar core struc-
tural organization for all amyloid fibrils 
(Fig. 1A–C).
Toxic and Functional Properties 
of Amyloid
In amyloid associated disease, amy-
loid fibrils are deposited in tissues, form-
ing insoluble structures and sometimes 
replacing cells. For example, in lysozyme 
amyloidosis, much of the kidney can be 
replaced by amyloid deposits.13 However, 
some small oligomeric intermediates 
formed during the self-assembly by amy-
loidogenic precursor proteins or peptides 
have toxic potential and are involved in 
the cell death observed in these misfold-
ing and neurodegenerative diseases,14 
although not all small oligomeric inter-
mediates have been found to be toxic. 
For example, HypF can be induced to 
form both toxic and non-toxic oligomeric 
species.15 Equally, small fibrillar oligo-
mer species or fibril fragments have also 
been found to possess toxic potential.16-18 
Indeed, a β-sheet protein that has been 
designed to form amyloid-like oligo-
mers leads to a cascade of toxic events 
following expression in human cells.17 
Recently, it has become clear that amy-
loid structures are quite commonly found 
in natural systems, and there are increas-
ing reports of such functional amyloid 
structures that provide scaffold, support, 
and protection due to their stability and 
strength.19 For example, E. coli produces 
curli that forms a layer of amyloid fibrils 
on the outside of the organism,20 while 
amyloid has also been identified as form-
ing a protective layer to melanosomes.21 
Interestingly, the self-assembly of each of 
these systems is carefully controlled by 
the organism,22 although whether such 
functional amyloid assemblies inher-
ently lack toxic potential remains to be 
established.
These observations together with 
recent advances in the determination of 
the sequence and structural properties of 
amyloid fibrils raise an important ques-
tion: Why are some amyloid assemblies 
toxic, while others are inert or toler-
ated, even to the extent that they may 
be evolved to perform useful biological 
functions, despite the fact that the end 
products of amyloid assembly share a 
common cross-β structural organization?
In Search of Structure and 
Assembly Properties that Confer 
Toxic Potential
The varied toxic potential of amyloid 
assemblies may involve several structural 
and assembly properties such as differ-
ent levels of structural rigidity, stabil-
ity (thermal, enzymatic, or mechanical), 
and surface protection of amyloid fibrils 
(Fig. 1D–H). These form testable hypoth-
eses that can be examined by studies that 
connect sequence, structure, morphology, 
and toxicity of amyloid assemblies.
Some short amyloidogenic peptides 
identified by algorithms and crystal-
lography, are some of the most efficient 
and effective amyloid fibril formers. 
They self-assemble rapidly and effec-
tively, forming highly organized and 
rigid fibrils and sometimes crystal-like 
aggregates23 (Fig. 2). Using these highly 
effective self-assembling peptides, we 
investigated the cytotoxic properties of 
some of these rigid crystal-like assemblies 
in neuroblastoma cell-line cultures, com-
pared with toxic, oligomeric Aβ(1−42) 
(Aβ
42
) (Fig. 3). We investigated the 
effect of soluble peptide as well as crys-
talline and fibrillar aggregates formed 
by the peptide KFFEAAAKKFFE and 
variants of this sequence.24 Interestingly, 
none affected the reduction of MTT to 
formazan, a process that occurs in viable 
cells with active metabolism, suggesting 
that these aggregates possess little cyto-
toxic potential. For comparison, it is well 
known that Aβ, in various forms, is toxic 
to cells. Aβ peptides self-assemble rap-
idly,25 particularly Aβ
42
. However, Aβ
42
 
does form significant populations of 
potentially long-lived and toxic interme-
diates that can be visualized by electron 
microscopy.16,26 Aβ also has the potential 
to form a wide range of different spe-
cies and fibril polymorphs.27,28 Thus, the 
lack of structural rigidity in the fibrillar 
assembly products of Aβ amyloid may 
reflect the ability of Aβ to participate in 
heterogeneous assembly reactions that 
Figure 1. Detailed atomic resolution structures of amyloid leads to different physical properties, 
which in turn produce varied biological functions. (A–C) Structural models depicting the amyloid 
cross-β molecular architecture. (A) the crystal structure of GNNQQNY (2OMM.pdb),7 (B) a model of 
fibrous nanocrystals formed by KFFEAAAKKFFE,8 (C) a model structure of fibrils formed by ViYKi.9 
(D–H) schematic illustrations of morphologies that may result in different biological properties. 
(D) illustrations of flexible and heterogeneous fibrils compared with (E) rigid and crystal-like fibrils. 
(F) illustrations showing long and thermally, mechanically and/or enzymatically stable fibrils com-
pared with (G) short, fragile, and unstable fibrils with non-interacting surfaces and (H) fibrils with 
interacting or sticky surfaces.
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could form a large number of different 
intermediate and fibril species, some of 
which may possess cytotoxic potential.
Another property to consider is the sta-
bility of amyloid fibrils, and their revers-
ibility and disassembly processes. The 
assembly process of amyloid is reversible, 
and this dynamic process is normally 
favored toward the formation of amyloid 
fibrils. Thus, fibrils that are thermody-
namically and/or kinetically more stable 
will disassemble more slowly and, there-
fore, shed a lower population of poten-
tially cytotoxic species29 from fibril ends 
at a lower rate. The mechanical stability 
of amyloid fibrils may also play a key role 
in generating small fibril fragments (or 
fibrillar oligomers) that possess cytotoxic 
potential through fibril breakage pro-
cesses induced by mechanical or enzy-
matic action.30,31 Thus, understanding the 
origin of the toxic properties of amyloid 
assemblies will involve the characteriza-
tion of the stability of fibrils toward dif-
ferent perturbations, and the sequence and 
structural properties that confer the dif-
ferent stabilities of fibrils.
The surface properties of amyloid 
fibrils may also influence their toxic 
potential. For example, small oligomeric 
species and fibrillar fragments have all 
been shown to be able to disrupt lipid 
membranes.18,32,33 For fibril fragments, 
fibril ends have been seen as the active sur-
faces that interact with membranes.32-34 
Thus, the lack of surface protection that 
can minimize aberrant interactions at 
the sites of amyloid growth may play an 
important role in terms of their cytotoxic 
potential. Such protection, for example 
in the form of a mechanism involv-
ing capping of growth competent fibril 
ends, may also be a generic feature that 
provides a host organism the means to 
control functional amyloid. Surfaces 
that promote fibril-fibril interactions, or 
the packing between proto-filaments in 
fibrils may further modulate the reac-
tivity and stability of amyloid fibrils, 
deposits, or plaques, in turn affecting 
the generation of potentially toxic spe-
cies through depolymerisation. Detailed 
atomic resolution structural information 
of amyloid fibrils may inform on their 
surface properties, for example revealing 
hydrophobic patches that may act as 
“sticky” sites that can promote aberrant 
interactions or fibril clumping.
Amyloid by Design
Finally, a large area of synthetic biol-
ogy has grown from the use of β-sheet 
structural growth, providing nanowires 
and hydrogels composed of amyloid-like 
structures.11,35,36 The amyloid struc-
ture may prove to be useful and may be 
exploited to form a range of materials.37 
These fibrils are formed by repetitive pre-
cursor sequences, often short peptides, 
that form highly organized fibrils. These 
can be decorated further, or they can 
be used to form hydrogels or wires.38,39 
β-sheet based materials have been used in 
tissue engineering and for enabling cell 
growth, showing they are non-toxic.35
Figure  2. Structure and morphology of different amyloid aggregates assembled from 
KFFEAAAKKFFE 8 and variants 24 results in altered morphology and assembly properties. 
images show aggregated peptide samples 1: KFFEAAAKKFFE in PBS, 2: rFFEAAAKrFFE in PBS, 
3: AFFEAAAAKFFE in water, and 4: KFFEAAAAKFFE in water. Upper row shows negative stain trans-
mission electron microscope images (black scale bars = 200 nm). Lower row shows atomic force 
microscopy height images (white scale bars = 2 μm).
Figure 3. the effect of assembled peptide morphology and composition on neuroblastoma cells. 
Mtt assays (Molecular Probes) were performed according to the manufacturers protocol. A neu-
roblastoma cell line (SH-SY5Y) was treated with 10 μM monomer equivalent concentrations of 
aggregated peptide samples 1: KFFEAAAKKFFE in PBS 2: rFFEAAAKrFFE in PBS, 3: AFFEAAAAKFFE 
in water, and 4: KFFEAAAAKFFE in water (Fig. 2). Cells were also treated with soluble KFFEAAAKKFFE 
in water (labeled Sol), a buffer only control (labeled Ctrl) or Aβ42 oligomers (labeled Olig). Changes 
in the Mtt response after 24 h were monitored and are shown relative to the buffer control and 
error bars correspond to SEM over 3 replicates. Only Aβ42 oligomers
16,26 induce cellular dysfunction 
resulting in a reduction to 60% compared with control. the student t test comparison between olig 
and ctrl showed significance of P<0.001 labelled ***.
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Ultimately, engineering synthetic amy-
loid as a novel and safe bionanomaterial 
will rely on the understanding of the struc-
tural factors that underpin toxic proper-
ties so that the toxic potential of designed 
amyloid materials can be minimized or 
avoided. In the same way, understanding 
the same underlying principles will be key 
in understanding amyloid disease so that 
the toxic potential of disease associated 
amyloid can be inhibited.
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